+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generic Drugs Market 2025-2029- Product Image
Generic Drugs Market 2025-2029- Product Image
New

Generic Drugs Market 2025-2029

  • PDF Icon

    Report

  • 221 Pages
  • March 2025
  • Region: Global
  • TechNavio
  • ID: 5459513
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The generic drugs market is forecasted to grow by USD 217.4 billion during 2024-2029, accelerating at a CAGR of 7.6% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives to branded medicines, increased outsourcing of drug discovery and development, and rising expiry of patents on branded drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The generic drugs market is segmented as below:

By Route Of Administration

  • Oral
  • Injectables
  • Topical
  • Inhalers

By Type

  • Small-molecule generics
  • Biosimilars

By Application

  • Anti-infectives
  • CNS
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of RPA as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising mergers and acquisitions among companies and emergence of hospital-owned generics will lead to sizable demand in the market.

The report on the generic drugs market covers the following areas:

  • Generic Drugs Market sizing
  • Generic Drugs Market forecast
  • Generic Drugs Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., DR Reddys Laboratories Ltd., Eli Lilly and Co., Fresenius SE and Co. KGaA, GlaxoSmithKline PLC, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Generic Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Generic Drugs Market 2019 - 2023 ($ billion)
5.2 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.4 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on Global Generic Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Route of Administration
8.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
8.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
8.3 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
8.4 Injectables - Market size and forecast 2024-2029
Chart on Injectables - Market size and forecast 2024-2029 ($ billion)
Data Table on Injectables - Market size and forecast 2024-2029 ($ billion)
Chart on Injectables - Year-over-year growth 2024-2029 (%)
Data Table on Injectables - Year-over-year growth 2024-2029 (%)
8.5 Topical - Market size and forecast 2024-2029
Chart on Topical - Market size and forecast 2024-2029 ($ billion)
Data Table on Topical - Market size and forecast 2024-2029 ($ billion)
Chart on Topical - Year-over-year growth 2024-2029 (%)
Data Table on Topical - Year-over-year growth 2024-2029 (%)
8.6 Inhalers - Market size and forecast 2024-2029
Chart on Inhalers - Market size and forecast 2024-2029 ($ billion)
Data Table on Inhalers - Market size and forecast 2024-2029 ($ billion)
Chart on Inhalers - Year-over-year growth 2024-2029 (%)
Data Table on Inhalers - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ billion)
Data Table on Market opportunity by Route of Administration ($ billion)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Small-molecule generics - Market size and forecast 2024-2029
Chart on Small-molecule generics - Market size and forecast 2024-2029 ($ billion)
Data Table on Small-molecule generics - Market size and forecast 2024-2029 ($ billion)
Chart on Small-molecule generics - Year-over-year growth 2024-2029 (%)
Data Table on Small-molecule generics - Year-over-year growth 2024-2029 (%)
9.4 Biosimilars - Market size and forecast 2024-2029
Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Application
10.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
10.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
10.3 Anti-infectives - Market size and forecast 2024-2029
Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
10.4 CNS - Market size and forecast 2024-2029
Chart on CNS - Market size and forecast 2024-2029 ($ billion)
Data Table on CNS - Market size and forecast 2024-2029 ($ billion)
Chart on CNS - Year-over-year growth 2024-2029 (%)
Data Table on CNS - Year-over-year growth 2024-2029 (%)
10.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.10 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.11 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.16 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.5 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.6 Baxter International Inc.
Baxter International Inc. - Overview
Baxter International Inc. - Business segments
Baxter International Inc. - Key news
Baxter International Inc. - Key offerings
Baxter International Inc. - Segment focus
SWOT
15.7 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.8 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
SWOT
15.9 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
15.10 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.11 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
SWOT
15.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Market Segmentation by Application
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Generic Drugs Market 2019 - 2023 ($ billion)
Exhibits 26: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 39: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Route of Administration
Exhibits 41: Data Table on Comparison by Route of Administration
Exhibits 42: Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits 43: Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits 44: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Injectables - Market size and forecast 2024-2029 ($ billion)
Exhibits 47: Data Table on Injectables - Market size and forecast 2024-2029 ($ billion)
Exhibits 48: Chart on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Injectables - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Topical - Market size and forecast 2024-2029 ($ billion)
Exhibits 51: Data Table on Topical - Market size and forecast 2024-2029 ($ billion)
Exhibits 52: Chart on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Topical - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Inhalers - Market size and forecast 2024-2029 ($ billion)
Exhibits 55: Data Table on Inhalers - Market size and forecast 2024-2029 ($ billion)
Exhibits 56: Chart on Inhalers - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Inhalers - Year-over-year growth 2024-2029 (%)
Exhibits 58: Market opportunity by Route of Administration ($ billion)
Exhibits 59: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits 60: Chart on Type - Market share 2024-2029 (%)
Exhibits 61: Data Table on Type - Market share 2024-2029 (%)
Exhibits 62: Chart on Comparison by Type
Exhibits 63: Data Table on Comparison by Type
Exhibits 64: Chart on Small-molecule generics - Market size and forecast 2024-2029 ($ billion)
Exhibits 65: Data Table on Small-molecule generics - Market size and forecast 2024-2029 ($ billion)
Exhibits 66: Chart on Small-molecule generics - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Small-molecule generics - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Exhibits 69: Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits 72: Market opportunity by Type ($ billion)
Exhibits 73: Data Table on Market opportunity by Type ($ billion)
Exhibits 74: Chart on Application - Market share 2024-2029 (%)
Exhibits 75: Data Table on Application - Market share 2024-2029 (%)
Exhibits 76: Chart on Comparison by Application
Exhibits 77: Data Table on Comparison by Application
Exhibits 78: Chart on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Exhibits 79: Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ billion)
Exhibits 80: Chart on Anti-infectives - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on CNS - Market size and forecast 2024-2029 ($ billion)
Exhibits 83: Data Table on CNS - Market size and forecast 2024-2029 ($ billion)
Exhibits 84: Chart on CNS - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on CNS - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 87: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 88: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 90: Market opportunity by Application ($ billion)
Exhibits 91: Data Table on Market opportunity by Application ($ billion)
Exhibits 92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 95: Chart on Geographic comparison
Exhibits 96: Data Table on Geographic comparison
Exhibits 97: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 98: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 99: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 102: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 106: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 107: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 114: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 118: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 122: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 126: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 130: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 131: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 134: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 138: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 139: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 142: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 146: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits 147: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 150: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 151: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 153: Market opportunity By Geographical Landscape ($ billion)
Exhibits 154: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 155: Impact of drivers and challenges in 2024 and 2029
Exhibits 156: Overview on criticality of inputs and factors of differentiation
Exhibits 157: Overview on factors of disruption
Exhibits 158: Impact of key risks on business
Exhibits 159: Companies covered
Exhibits 160: Company ranking index
Exhibits 161: Matrix on companies position and classification
Exhibits 162: Amgen Inc. - Overview
Exhibits 163: Amgen Inc. - Product / Service
Exhibits 164: Amgen Inc. - Key news
Exhibits 165: Amgen Inc. - Key offerings
Exhibits 166: SWOT
Exhibits 167: Aurobindo Pharma Ltd. - Overview
Exhibits 168: Aurobindo Pharma Ltd. - Product / Service
Exhibits 169: Aurobindo Pharma Ltd. - Key offerings
Exhibits 170: SWOT
Exhibits 171: Baxter International Inc. - Overview
Exhibits 172: Baxter International Inc. - Business segments
Exhibits 173: Baxter International Inc. - Key news
Exhibits 174: Baxter International Inc. - Key offerings
Exhibits 175: Baxter International Inc. - Segment focus
Exhibits 176: SWOT
Exhibits 177: Biocon Ltd. - Overview
Exhibits 178: Biocon Ltd. - Business segments
Exhibits 179: Biocon Ltd. - Key offerings
Exhibits 180: Biocon Ltd. - Segment focus
Exhibits 181: SWOT
Exhibits 182: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 183: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 184: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 185: SWOT
Exhibits 186: Cipla Inc. - Overview
Exhibits 187: Cipla Inc. - Business segments
Exhibits 188: Cipla Inc. - Key news
Exhibits 189: Cipla Inc. - Key offerings
Exhibits 190: Cipla Inc. - Segment focus
Exhibits 191: SWOT
Exhibits 192: Dr Reddys Laboratories Ltd. - Overview
Exhibits 193: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 194: Dr Reddys Laboratories Ltd. - Key news
Exhibits 195: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 196: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 197: SWOT
Exhibits 198: Fresenius SE and Co. KGaA - Overview
Exhibits 199: Fresenius SE and Co. KGaA - Business segments
Exhibits 200: Fresenius SE and Co. KGaA - Key news
Exhibits 201: Fresenius SE and Co. KGaA - Key offerings
Exhibits 202: Fresenius SE and Co. KGaA - Segment focus
Exhibits 203: SWOT
Exhibits 204: Merck and Co. Inc. - Overview
Exhibits 205: Merck and Co. Inc. - Business segments
Exhibits 206: Merck and Co. Inc. - Key news
Exhibits 207: Merck and Co. Inc. - Key offerings
Exhibits 208: Merck and Co. Inc. - Segment focus
Exhibits 209: SWOT
Exhibits 210: Novartis AG - Overview
Exhibits 211: Novartis AG - Business segments
Exhibits 212: Novartis AG - Key news
Exhibits 213: Novartis AG - Key offerings
Exhibits 214: Novartis AG - Segment focus
Exhibits 215: SWOT
Exhibits 216: Pfizer Inc. - Overview
Exhibits 217: Pfizer Inc. - Product / Service
Exhibits 218: Pfizer Inc. - Key news
Exhibits 219: Pfizer Inc. - Key offerings
Exhibits 220: SWOT
Exhibits 221: Sanofi SA - Overview
Exhibits 222: Sanofi SA - Business segments
Exhibits 223: Sanofi SA - Key news
Exhibits 224: Sanofi SA - Key offerings
Exhibits 225: Sanofi SA - Segment focus
Exhibits 226: SWOT
Exhibits 227: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 228: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 229: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 230: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 231: SWOT
Exhibits 232: Teva Pharmaceutical In

Executive Summary

The following companies are recognized as the key players in the global generic drugs market: Amgen Inc., Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of rpa."

According to the report, one of the major drivers for this market is the low-cost alternatives to branded medicines.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Biocon Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030 - Product Image

Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
United States Generic Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Generic Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • United States
From
North America Generic Drugs Market Report and Forecast 2024-2032 - Product Image

North America Generic Drugs Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • North America
From
Generic Drugs - Global Strategic Business Report - Product Image

Generic Drugs - Global Strategic Business Report

  • Report
  • 711 Pages
  • Global
From
Generic Pharmaceuticals Market Opportunities and Strategies to 2033 - Product Image

Generic Pharmaceuticals Market Opportunities and Strategies to 2033

  • Report
  • 327 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.